• 主题
高级搜索  >
历史搜索 清空历史
首页> 外国专利> Medicinal products for the causal treatment of skin disease 'Neurodermitis' (Dermatitis vasculosa) in the form of a percutaneous ointment preparation

Medicinal products for the causal treatment of skin disease 'Neurodermitis' (Dermatitis vasculosa) in the form of a percutaneous ointment preparation

机译：经皮软膏制剂形式的用于因果治疗“神经皮炎”（Dermatitis vasculosa）皮肤病的药物

页面导航
  • 摘要
  • 著录项
  • 相似文献

摘要

medicinal products for the causal treatment of skin disease "Neurodermitis" (Dermatitis vasculosa) in the form of a percutaneous ointment preparation,characterized by the fact thatthe active substances listed below are the main components of the healing album which are capable of identifying the cause of autosomal dominant inherited skin disease "Neurodermitis" (Dermatitis vasculosa), which can be identified as generalised capillary vascular spasm, which e the main symptoms of Pruritus and Dermographia alba should be eliminated,with a particular intention,the number of components of the medicinal product (medicinal albums) to be limited to only a few (maximum 20 substances), as the persons affected by the neurodermatitis (dermatitis vasculosa) often tend to be allergic and allergic (antibody development against new substances) and to where necessary, to keep the allergy tests of the substances to be tested transparent.Active:<TableGroup colSep="0" cols="3" rowSep="1"><Colspec colName="col1" colSep="0" colWidth="5*"/><Colspec colName="col2" colSep="0" colWidth="67*"/><Colspec colName="col3" colSep="0" colWidth="59*"/><Tbody><Row rowSep="0"><entry align="left" colName="col1" valign="top">1.</entry><entry align="left" colName="col2" moreRows="1" rowSep="1" valign="top">Muskulotropes Vasospasmolytikum, gleichzeitig als Antipruriginosum: (nur peripher (kapillär) wirksam)</entry><entry align="left" colName="col3" valign="top">Papaverin,</entry></Row><Row rowSep="1"><entry align="left" colName="col1" valign="top"/><entry align="left" colName="col3" valign="top">Moxaverin.</entry></Row><Row rowSep="0"><entry align="left" colName="col1" valign="top">2.</entry><entry align="left" colName="col2" valign="top">Antihistamin:</entry><entry align="left" colName="col3" valign="top">Dimetinden</entry></Row><Row rowSep="0"><entry align="left" colName="col1" valign="top"/><entry align="left" colName="col2" valign="top"/><entry align="left" colName="col3" valign="top">Homöopathische Substanzen:</entry></Row><Row rowSep="0"><entry align="left" colName="col1" valign="top"/><entry align="left" colName="col2" valign="top"/><entry align="left" colName="col3" valign="top">Luffa operculata Trit. D4</entry></Row><Row rowSep="0"><entry align="left" colName="col1" valign="top"/><entry align="left" colName="col2" valign="top"/><entry align="left" colName="col3" valign="top">Galphimia glauca Trit D3</entry></Row><Row rowSep="1"><entry align="left" colName="col1" valign="top"/><entry align="left" colName="col2" valign="top"/><entry align="left" colName="col3" valign="top">Cardiospermum D3</entry></Row><Row rowSep="1"><entry align="left" colName="col1" valign="top">3.</entry><entry align="left" colName="col2" valign="top">Lokalanästhetikum:</entry><entry align="left" colName="col3" valign="top">Lidocain</entry></Row><Row rowSep="0"><entry align="left" colName="col1" valign="top">4.</entry><entry align="left" colName="col2" valign="top">Antiphlogistikum:</entry><entry align="left" colName="col3" valign="top">Phytopharmaka:</entry></Row><Row rowSep="0"><entry align="left" colName="col1" valign="top"/><entry align="left" colName="col2" valign="top"/><entry align="left" colName="col3" valign="top">Pflanzenextrakte aus</entry></Row><Row rowSep="0"><entry align="left" colName="col1" valign="top"/><entry align="left" colName="col2" valign="top"/><entry align="left" colName="col3" valign="top">Arnika</entry></Row><Row rowSep="0"><entry align="left" colName="col1" valign="top"/><entry align="left" colName="col2" valign="top"/><entry align="left" colName="col3" valign="top">Propolis</entry></Row><Row rowSep="1"><entry align="left" colName="col1" valign="top"/><entry align="left" colName="col2" valign="top"/><entry align="left" colName="col3" valign="top">Fenchel</entry></Row><Row rowSep="1"><entry align="left" colName="col1" valign="top">5.</entry><entry align="left" colName="col2" valign="top">Dermatoregenerativum:</entry><entry align="left" colName="col3" valign="top">Zink</entry></Row><Row rowSep="0"><entry align="left" colName="col1" valign="top">6.</entry><entry align="left" colName="col2" valign="top">Thermoregulans, gleichzeitig als Antipruriginosum:</entry><entry align="left" colName="col3" valign="top">Menthol</entry></Row></Tbody></TableGroup></TableFormula></Table> </span> <span class="z_kbtn z_kbtnclass hoverxs" style="display: none;">展开▼</span> </div> <div class="translation abstracttxt"> <span class="zhankaihshouqi fivelineshidden" id="abstract"> <span>机译：</span>用于经皮软膏制剂形式的皮肤病“神经皮炎”（Dermatitis vasculosa）的因果治疗药物，事实是以下所列的活性物质是治疗专辑中的主要成分，能够确定常染色体显性遗传性皮肤病“神经皮炎”（Dermatitis vasculosa）的原因，可以将其识别为广义毛细血管痉挛，这是主要的应当消除瘙痒和白皮病的症状，有特定的意图由于受神经性皮炎（血管炎）影响的人往往趋向于过敏和过敏（针对新物质的抗体开发），因此药品的成分（药品专辑）的数量应限制为很少（最多20种物质）并在必要时保持被测物质的过敏测试透明。活性：<Table> <TableFormula> <Title /> <TableGroup colSep =“ 0” cols =“ 3” rowSep =“ 1”> <Colspec colName =“ col1” colSep =“ 0” colWidth =“ 5 *” /> <Colspec colName =“ col2” colSep =“ 0” colWidth =“ 67 *” /> <Colspec colName =“ col3” colSep =“ 0” colWidth =“ 59 *” /> <Tbody> <行rowSep =“ 0”> <条目align =“ left” colName =“ col1” valign =“ top”> 1。</ entry> <entry align =“ left” colName =“ col2” moreRows =“ 1” rowSep =“ 1” valign =“ top” > Muskulotropes Vasospasmolytikum，抗衰老：（nur外围（kapillär）wirksam）</ entry> <entry align =“ left” colName =“ col3” valign =“ top”> Papaverin，</ entry> </ Row> <Row rowSep =“ 1”> <entry align =“ left” colName =“ col1” valign =“ top” /> <entry align =“ left” colName =“ col3” valign =“ top”> Moxaverin。</ entry> < / Row> <行rowSep =“ 0”> <entry align =“ left” colName =“ col1” valign =“ top”> 2。</ entry> <entry align =“ left” colName =“ col2” valign =“ top“>抗组蛋白：</ entry> <entry align =” left“ colName =” col3“ valign =” top“> Dimetinden </ entry> </ Row> <Row rowSep =” 0“> <entry align =” left “ colName =” col1“ valign =” top“ /> <输入align =” left“ colNa me =“ col2” valign =“ top” /> <entry align =“ left” colName =“ col3” valign =“ top”>HomöopathischeSubstanzen：</ entry> </ Row> <Row rowSep =“ 0”> <条目align =“ left” colName =“ col1” valign =“ top” /> <输入align =“ left” colName =“ col2” valign =“ top” /> <entry align =“ left” colName =“ col3” valign =“ top”> Luffa operculata Trit。 D4 </ entry> </ Row> <Row rowSep =“ 0”> <entry align =“ left” colName =“ col1” valign =“ top” /> <entry align =“ left” colName =“ col2” valign = “ top” /> <entry align =“ left” colName =“ col3” valign =“ top”> Galphimia glauca Trit D3 </ entry> </ Row> <Row rowSep =“ 1”> <entry align =“ left” colName =“ col1” valign =“ top” /> <entry align =“ left” colName =“ col2” valign =“ top” /> <entry align =“ left” colName =“ col3” valign =“ top”> Cardiospermum D3 </ entry> </ Row> <Row rowSep =“ 1”> <entry align =“ left” colName =“ col1” valign =“ top”> 3。</ entry> <entry align =“ left” colName = “ col2” valign =“ top”>Lokalanästhetikum：</ entry> <entry align =“ left” colName =“ col3” valign =“ top”> Lidocain </ entry> </ Row> <Row rowSep =“ 0”> <entry align =“ left” colName =“ col1” valign =“ top”> 4。</ entry> <entry align =“ left” colName =“ col2” valign =“ top”> Antiphlogistikum：</ entry> <entry align =“ left” colName =“ col3” valign =“ top”> Phytopharmaka：</ entry> </ Row> <Row rowSep =“ 0”> <entry align =“ left” colName =“ col1” valign =“ top “ /> <entry align =” left“ colName =” col2“ valign =” top“ /> <entry align =” left“ colName =” col3“ va lign =“ top”> Pflanzenextrakte aus </ entry> </ Row> <Row rowSep =“ 0”> <entry align =“ left” colName =“ col1” valign =“ top” /> <entry align =“ left” colName =“ col2” valign =“ top” /> <entry align =“ left” colName =“ col3” valign =“ top”>阿妮卡</ entry> </ Row> <Row rowSep =“ 0”> <entry align =“ left” colName =“ col1” valign =“ top” /> <entry align =“ left” colName =“ col2” valign =“ top” /> <entry align =“ left” colName =“ col3” valign =“ top“>蜂胶</ entry> </ Row> <Row rowSep =” 1“> <entry align =” left“ colName =” col1“ valign =” top“ /> <entry align =” left“ colName =” col2 “ valign =” top“ /> <entry align =” left“ colName =” col3“ valign =” top“>芬切尔</ entry> </ Row> <Row rowSep =” 1“> <entry align =” left“ colName =“ col1” valign =“ top”> 5。</ entry> <entry align =“ left” colName =“ col2” valign =“ top”> Dermatoregenerativum：</ entry> <entry align =“ left” colName = “ col3” valign =“ top”>缩放</ entry> </ Row> <行rowSep =“ 0”> <entry align =“ left” colName =“ col1” valign =“ top”> 6。</ entry> <entry align =“ left” colName =“ col2” valign =“ top”> Thermoregulans，gleichzeitig als Antipruriginosum：</ entry> <entry al ign =“ left” colName =“ col3” valign =“ top”>薄荷醇</ entry> </ Row> </ Tbody> </ TableGroup> </ TableFormula> </ Table> </span> <span class="z_kbtn z_kbtnclass hoverxs" style="display: none;">展开▼</span> </div> </div> <div class="record"> <h2 class="all_title" id="enpatent33">著录项</h2> <div class="getdents"> <ul> <li> <p><span>公开/公告号</span><span>DE202019000523U1</span></p> <p><span>专利类型</span><span></span></p> </li> <li> <p><span>公开/公告日</span><span>2019-06-27</span></p> <p><span>原文格式</span><span>PDF</span></p> </li> <li> <div class="apply"> <p><span style="width: 90px;display: inline-block;">申请/专利权人</span><span id="patentee" class="threelineshidden zhankaihshouqi"> <a href="/search.html?doctypes=12_13&sertext=EBISAN JOSEPH PRINCE AFINI-AWANI&option=232">EBISAN JOSEPH PRINCE AFINI-AWANI;</a> </span></p> <span class="designer hoverxs" style="display: none;">展开▼</span> </div> <p><span>申请/专利号</span><span style="width: 250px;">DE202019000523U1</span></p> </li> <li> <div class="apply"> <p><span style="width: 90px;display: inline-block;">发明设计人</span><span id="patentee" class="threelineshidden zhankaihshouqi"> </span></p> <span class="designer hoverxs" style="display: none;">展开▼</span> </div> <p><span>申请日</span><span>2019-02-01</span></p> </li> <li> <p style="width: 100%;"><span>分类号</span><span style="width: 80%;">A61K31/472;A61K31/137;A61K31/44;A61K36/42;A61K36/185;A61K36/77;A61K31/167;A61K36/28;A61K36/235;A61K33/30;A61K36/534;A61K31/045;A61P17;A61P17/06;A61P17/04;</span> </p> </li> <li> <p style="width: 100%;"><span>国家 </span><span style="width: 93%;">DE</span></p> </li> <li><p style="width: 100%;"> <span >入库时间</span> <span>2022-08-21 11:44:09</span></p> </li> </ul> </div> </div> </div> <div class="literature cardcommon"> <div class="similarity"> <h3 class="all_title" id="enpatent66">相似文献</h3> <div class="similaritytab clearfix"> <ul > <li >专利</li> <li >外文文献</li> <li >中文文献</li> </ul> </div> <div class="similarity_details"> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/patent-detail/06120107543377.html">一种用于治疗神经性皮炎的药物制剂</a> <b>[P]</b> . <span> 中国专利： CN105055818A </span> <span> . 2015-11-18</span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/patent-detail/06120107650021.html">一种用于治疗神经性皮炎的药物制剂</a> <b>[P]</b> . <span> 中国专利： CN105147965A </span> <span> . 2015-12-16</span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/patent-detail/06130413895464.html">Medicinal products for the causal treatment of the skin disorder "atopic dermatitis" (dermatitis vasculosa) in the form of a percutaneously administrable ointment preparation</a> <b>[P]</b> . <span> 德国专利： DE202015003712U1 </span> <span> . 2015-10-15</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译： </span>用于经皮给药的软膏制剂形式的因果性“特应性皮炎”（vastitis vasculosa）皮肤病的因果治疗药物 </p> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/patent-detail/06130402934148.html">Medicament for the causal treatment of the skin disease "atopic dermatitis" (dermatitis vasculosa) in the form of a percutaneously administered ointment preparation</a> <b>[P]</b> . <span> 德国专利： DE202019000523U1 </span> <span> . 2019-05-21</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译： </span>用于经皮给药的软膏制剂形式的因果治疗“特应性皮炎”（vastitis vasculosa）皮肤病的药物 </p> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/patent-detail/06130413895465.html">medicine for causal treatment of skin disease "atopic dermatitis (dermatitis vasculosa) in the form of a percutaneous applizierbaren salbenpru00e4parates</a> <b>[P]</b> . <span> 德国专利： DE202015003712U1 </span> <span> . 2015-11-05</span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译： </span>皮肤病的因果治疗药物“特应性皮炎（vastitis vasculosa）”以经皮贴敷的形式出现 </p> </li> </ul> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/academic-journal-cn_traditional-medical-research-english_thesis/0201231566412.html">Pseudolaric acid B extracted from the Chinese medicinal herb Cortex Pseudolaricis ameliorates DNFB-induced atopic dermatitis-like skin lesions in BALB/c mice</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Yi-Teng Wang&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Yi-Teng Wang,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Min Zhang&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Min Zhang,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Mei-Lun Liu&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Mei-Lun Liu,</a> <a href="/journal-foreign-28397/" target="_blank" rel="nofollow" class="tuijian_authcolor">传统医学研究（英文版） .</a> <span>2017</span><span>,第004期</span> </span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016430429.html">Preparation of a gel-forming ointment base applicable to the recovery stage of bedsore and clinical evaluation of a treatment method with different ointment bases suitable to each stage of bedsore</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Shigeyama M&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Shigeyama M </a> <a href="/journal-foreign-36982/" target="_blank" rel="nofollow" class="tuijian_authcolor">藥學雜誌 .</a> <span>2004</span><span>,第2期</span> </span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704026520179.html">Preparation of a gel-forming ointment base applicable to the recovery stage of bedsore and clinical evaluation of a treatment method with different ointment bases suitable to each stage of bedsore</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Shigeyama M&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Shigeyama M </a> <a href="/journal-foreign-36982/" target="_blank" rel="nofollow" class="tuijian_authcolor">藥學雜誌 .</a> <span>2004</span><span>,第2期</span> </span> </div> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704021927434.html">Dupilumab-induced ocular surface disease (DIOSD) in patients with atopic dermatitis: clinical presentation, risk factors for development and outcomes of treatment with tacrolimus ointment</a> <b>[J]</b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> </a> <a href="/journal-foreign-15303/" target="_blank" rel="nofollow" class="tuijian_authcolor">British journal of ophthalmology .</a> <span>2020</span><span>,第6期</span> </span> </div> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/academic-conference-foreign_meeting-188059_thesis/020512798837.html">Monte Carlo simulation of novel procedures for highly conformal percutaneous radiation with keV-photons for tumor treatment in skin proximity</a> <b>[C]</b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=M. Petersheim&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">M. Petersheim,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=J. Hesser&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">J. Hesser,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=F. Wenz&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">F. Wenz </a> <a href="/conference-foreign-188059/" target="_blank" rel="nofollow" class="tuijian_authcolor">World congress on medical physics and biomedical engineering;International congress of the IUPESM .</a> <span>2011</span> </span> </div> </li> <li> <div> <b>6. </b><a class="enjiyixqcontent" href="/academic-degree-foreign_mphd_thesis/02061630981.html">Psoriasiform dermatitis in *CD18 deficient PL/J mice is a polygenic disease mediated by T lymphocytes</a> <b>[D] </b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Barlow, Shayne Caley.&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Barlow, Shayne Caley. </a> <span>2002</span> </span> </div> </li> <li> <div> <b>7. </b><a class="enjiyixqcontent" href="/academic-journal-foreign-pmc_detail_thesis/040001423620.html">The Efficacy and Safety of Jaungo a Traditional Medicinal Ointment in Preventing Radiation Dermatitis in Patients with Breast Cancer: A Prospective Single-Blinded Randomized Pilot Study</a> <b>[O] </b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Moonkyoo Kong&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Moonkyoo Kong,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Deok-Sang Hwang&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Deok-Sang Hwang,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Jee Young Lee&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Jee Young Lee,</a> <span>2016</span> </span> </div> </li> <li> <div> <b>8. </b><a class="enjiyixqcontent" href="/open-access_resources_thesis/01000130358754.html">Preparation of a Gel-Forming Ointment Base Applicable to the Recovery Stage of Bedsore and Clinical Evaluation of a Treatment Method with Different Ointment Bases Suitable to each Stage of Bedsore</a> <b>[O] </b> . <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Masato SHIGEYAMA&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Masato SHIGEYAMA,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Toyoaki OOGAYA&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Toyoaki OOGAYA,</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Tetsuzi YONEYAMA&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">Tetsuzi YONEYAMA,</a> <span>2001</span> </span> </div> </li> </ul> <ul style="display: none;"> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/academic-journal-cn_tmr-clinical-research_thesis/0201281573613.html">Meta-analysis of the efficacy and safety of sodium fusidate ointment and mupirocin ointment in the treatment of bacteria-infected skin disease</a> <b>[J]</b> <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Yuan Qin&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . Yuan Qin</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Qian Yi&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Qian Yi</a> <span> <a href="/journal-cn-55165/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . TMR临床研究 </a> </span> <span> . 2020</span><span>,第002期</span> </span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/academic-journal-cn_detail_thesis/0201294055043.html">Expression of Skin Barrier Protein Filaggrin in Skin Diseases without Atopic Dermatitis</a> <b>[J]</b> <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Yang Zhang&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . Yang Zhang</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Chen Tu&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Chen Tu</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Shuang Wang&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Shuang Wang</a> <span> <a href="/journal-cn-56593/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 生物科学与医学（英文） </a> </span> <span> . 2018</span><span>,第1期</span> </span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/academic-journal-cn_detail_thesis/0201296117576.html">A Novel Vehicle Formulation for Treatment of Inflammatory Skin Diseases</a> <b>[J]</b> <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=A. Zemtsov&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . A. Zemtsov</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=H. Hosier&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,H. Hosier</a> <span> <a href="/journal-cn-56375/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 化妆品、皮肤病及应用期刊（英文） </a> </span> <span> . 2013</span><span>,第1期</span> </span> </div> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/academic-journal-cn_traditional-medical-research-tmr_thesis/0201273993072.html">Pseudolaric acid B extracted from the Chinese medicinal herb Cortex Pseudolaricis ameliorates DNFB-induced atopic dermatitis-like skin lesions in BALB/c mice</a> <b>[J]</b> <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Yi-Teng Wang1&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . Yi-Teng Wang1</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Min Zhang2&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Min Zhang2</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=Mei-Lun Liu1&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,Mei-Lun Liu1</a> <span> <a href="/journal-cn-53903/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 传统医学研究（TMR） </a> </span> <span> . 2017</span><span>,第004期</span> </span> </div> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/academic-conference-cn_meeting-65495_thesis/020222944795.html">青石止痒软膏联合消风止痒汤辨证治疗神经性皮炎临床疗效评价</a> <b>[C]</b> <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=李纬&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 李纬</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=张丰川&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,张丰川</a> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=李元文&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor">,李元文</a> <span> <a href="/conference-cn-65495/" target="_blank" rel="nofollow" class="tuijian_authcolor"> . 中华中医药学会皮肤科分会第十四次学术年会 </a> <span> <span> . 2017</span> </span> </div> </li> <li> <div> <b>6. </b><a class="enjiyixqcontent" href="/academic-degree-domestic_mphd_thesis/020312810665.html">JAK1/JAK2抑制剂Momelotinib软膏的制备及其对特应性皮炎模型小鼠的治疗作用和机制研究</a> <b>[A] </b> <span> <a href="/search.html?doctypes=1_2_3_4_5_6_7_1-0_9_4-0&sertext=金文玉&option=202" target="_blank" rel="nofollow" class="tuijian_auth tuijian_authcolor"> . 金文玉</a> <span> . 2019</span> </span> </div> </li> </ul> </div> </div> <!--- <div class="correlation "> <h3 class="all_title" id="enpatent77">相关文献</h3> <div class="correlationtab clearfix"> <ul> <li class="active">中文文献</li> <li>外文文献</li> <li>专利</li> </ul> </div> <div class="correlation_details"> <ul> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>2. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>3. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>4. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>5. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>6. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>7. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>8. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>9. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> <li> <div> <b>10. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">从人学视角透视中国特色社会主义制度建设</a> <b>[J]</b> . <span> <a href="">郑东,</a> <a href="">郑东,</a> <a href="">郑东,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">管子学刊</a> <span>2003</span><span>,第60期</span><span>第4期</span> </span> </div> </li> </ul> <ul> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">分散型キャンパス情報ネットワークにおけるセキュリティ環境－香川大学情報ネットワークにおけるセキュリティ対策の現状と報告</a> <b>[J]</b> . <span> <a href="">河内一芳,</a> <a href="">曽根計俊,</a> <a href="">川口政秀,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">電子情報通信学会技術研究報告. 情報通信マネジメント. Information and Communication Management .</a> <span>2009</span><span>,第1卷</span><span>,第3期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译： </span>分布式校园信息网络中的安全环境-香川大学信息网络的现状和安全措施的报告 </p> </li> </ul> <ul> <li> <div> <b>1. </b><a class="enjiyixqcontent" href="/journal-foreign-detail/0704016504275.html">专利专利分散型キャンパス情報ネットワークにおけるセキュリティ環境－香川大学情報ネットワークにおけるセキュリティ対策の現状と報告</a> <b>[J]</b> . <span> <a href="">河内一芳,</a> <a href="">曽根計俊,</a> <a href="">川口政秀,</a> <a href="/journal-foreign-37017/" target="_blank" rel="nofollow" class="tuijian_authcolor">電子情報通信学会技術研究報告. 情報通信マネジメント. Information and Communication Management .</a> <span>2009</span><span>,第60期</span> </span> </div> <p class="zwjiyix translation" style="max-width: initial;height: auto;word-break: break-all;white-space: initial;text-overflow: initial;overflow: initial;"> <span>机译：</span>分布式校园信息网络中的安全环境-香川大学信息网络的现状和安全措施的报告 </p> </li> </ul> </div> </div>--> </div> </div> </div> </div> <div class="right "> </div> </div> <div id="thesis_down_palent" class="downloadBth" style="bottom: 19px;z-index: 999;" onclick="xz('06130402934147','13',6,1,this,'9999',0)" title="专利原文即时下载到本机" prompt="0101301">获取专利</div> <span id="06130402934147down" data-source="6," data-out-id="DE202019000147U1," data-f-source-id="6" data-title="Medicinal products for the causal treatment of skin disease 'Neurodermitis' (Dermatitis vasculosa) in the form of a percutaneous ointment preparation" data-price="20" data-transnum="0" style="display:none;"></span> <div class="right_btn"> <ul> <li class="gouwuche"> <!-- <a href="javascript:void(0);" onclick="link_analysis('/shoppingcart/auth/list.html',this)">购物车</a>--> </li> <li class="yijian"> <a href="javascript:void(0);" onclick="link_analysis('/mycenter/auth/complaint.html',this)" title="意见反馈">意见反馈</a> </li> <li class="top"> <a href="javascript:scrollTo(0,0);" title="回到顶部">回到顶部</a> </li> <li class="shouye"> <a href="/" title="首页">回到首页</a> </li> </ul> </div> <div class="xllindexfooter"> <div class="xllindexfootercenter"> <div class="xllindexfooterleft left" > <div class="xllindexfooterleftli"> <ul> <li><a href="/about.html" title="关于掌桥">关于掌桥</a></li> <li><a href="/help/helpmap.html" title="资源导航">资源导航</a></li> <li><a href="/help/helpguide.html" title="新手指南">新手指南</a></li> <li><a href="/help/helpcenter.html" title="常见问题">常见问题</a></li> <li><a href="/sitemap.html" title="网站地图">网站地图</a></li> <li><a href="/help/helpcenter.html?type=9" title="版权声明">版权声明</a></li> </ul> </div> <div class="xllindexfooterleft"> <p class="xllindexfooterlefteamil">客服邮箱：kefu@zhangqiaokeyan.com</p> <div class="xllindexfooterlefttcp"> <div class="xllindexfooterpoliceiimg"></div> <div class="xllindexfooterpoliceispan"> <span>京公网安备：11010802029741号 </span> <span>ICP备案号：<a href="https://beian.miit.gov.cn" rel="nofollow" target="_blank" title="ICP备案号">京ICP备15016152号-6</a></span> <span>六维联合信息科技 (北京) 有限公司©版权所有</span> </div> </div> </div> </div> <div class="xllindexfooterright left"> <ul> <li> <p style="font-weight: bold;">客服微信</p> <div></div> </li> <li> <p style="font-weight: bold;">服务号</p> <div></div> </li> </ul> </div> </div> </div> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery-1.12.4.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/lwlh_ajax.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zq.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/common.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/jquery.cookie.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/top.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/tip.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/login.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/down.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/search.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/searchtype.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/newmail.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/user/regist.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/zxs_solor/detail.js?v=5.7.8"></script> <script type="text/javascript" src="https://www.zhangqiaokeyan.com/statistics/static/pagecollection.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/tj.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/tip.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/sse.js?v=5.7.8"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/pushbaidu.js"></script> <script type="text/javascript" src="https://cdn.zhangqiaokeyan.com/js/common/history.js?v=5.7.8"></script> </body> </html>